Do undesirable effects of screening affect all-cause mortality in flexible sigmoidoscopy programmes? Experience from the Telemark Polyp Study 1983-1996

Autor: Hoff, G, Thiis-Evensen, E, Grotmol, T, Sauar, J, Vatn, M H, Moen, I E

Publikováno v: European Journal of Cancer Prevention, 2001 Apr 01. 10(2), 131-137.

Externí odkaz: https://www.jstor.org/stable/45050753

Manifestations of and factors influencing posttraumatic growth among Chinese Crohn's disease patients: a qualitative exploration.

Autor: Li, Hong¹, Chen, Dandan¹, Zhang, Chen¹, Zhou, Yunxian¹ yunxianzhou@zcum.edu.cn

Publikováno v: International Journal of Qualitative Studies on Health & Well-Being. Dec2024, Vol. 19 Issue 1, p1-12. 12p.

Review article: Measuring disease severity in inflammatory bowel disease - Beyond treat to target.

Autor: Swaminathan A; Department of Medicine, University of Otago Christchurch, Christchurch, New Zealand.; Department of Gastroenterology, Christchurch Hospital, Christchurch, New Zealand., Day AS; Department of Paediatrics, University of Otago Christchurch, Christchurch, New Zealand., Sparrow MP; Department of Gastroenterology, Alfred Health and School of Translational Medicine, Monash University, Australia., Peyrin-Biroulet L; Department of Gastroenterology, Nancy University Hospital, Vandoevre-les-Nancy, France.; Department of Gastroenterology, INFINY Institute, FHU-CURE, INSERM NGERE, Nancy University Hospital, Vandoeuvre-les-Nancy, France.; Groupe Hospitalier privé Ambroise Paré - Hartmann, Paris IBD Center, Neuilly sur Seine, France.; Division of Gastroenterology and Hepatology, McGill University Health Centre, Montreal, Quebec, Canada., Siegel CA; Center for Digestive Health, Section of Gastroenterology and Hepatology, Dartmouth Hitchcock Medical Centre, Lebanon, New Hampshire, USA., Gearry RB; Department of Medicine, University of Otago Christchurch, Christchurch, New Zealand.; Department of Gastroenterology, Christchurch Hospital, Christchurch, New Zealand.

Publikováno v: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2024 Nov; Vol. 60 (9), pp. 1176-1199.

Insights into Therapeutic Response Prediction for Ustekinumab in Ulcerative Colitis Using an Ensemble Bioinformatics Approach.

Autor: Koustenis, Kanellos¹ (AUTHOR) k.koustenis@yahoo.gr, Dovrolis, Nikolas² (AUTHOR) ndovroli@med.uoa.gr, Viazis, Nikos¹ (AUTHOR) nikos.viazis@gmail.com, Ioannou, Alexandros³ (AUTHOR), Bamias, Giorgos⁴ (AUTHOR) gbamias@gmail.com, Karamanolis, George⁵ (AUTHOR) georgekaramanolis@yahoo.co.uk, Gazouli, Maria² (AUTHOR) mgazouli@med.uoa.gr

Publikováno v: International Journal of Molecular Sciences. May2024, Vol. 25 Issue 10, p5532. 15p.

Health-related quality of life in patients with inflammatory bowel disease five years after the initial diagnosis.

Autor: Bernklev, T., Jahnsen, J., Aadland, E., Sauar, J., Schulz, T., Lygren, I., Henriksen, M., Stray, N., Kjellevold, ø., Vatn, M., Moum, B.

Publikováno v: Scandinavian Journal of Gastroenterology; Apr2004, Vol. 39 Issue 4, p365-373, 9p